ÂÜÀòÂÒÂ×

Carrie Brockway Wager has held various leadership positions in prominent companies such as Ascidian Therapeutics, Limelight Bio, and Pfizer. With a background in Chemistry and an MBA from MIT Sloan School of Management, Carrie has a proven track record of driving strategic and scientific operations within the pharmaceutical and biotech industry. Carrie's expertise lies in business planning, medical strategy, and business development, making their a valuable asset in the field of oncology and neuroscience research. Carrie currently serves on the MIT Sloan Alumni Board and the Miami University Alumni Advisory Board, showcasing their commitment to giving back to their alma maters.